🇺🇸 FDA
Patent

US 8962038

Nitrite formulations and their use as nitric oxide prodrugs

granted A61KA61K31/195A61K31/198

Quick answer

US patent 8962038 (Nitrite formulations and their use as nitric oxide prodrugs) held by The Board of Regents of the University of Texas System expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/195, A61K31/198, A61K31/375, A61K31/714